SBTX — Skinbiotherapeutics Share News
0.000.00%
- £40.11m
- £39.90m
- £1.21m
REG - SkinBioTherapeutics - Holding(s) in Company
AnnouncementREG - SkinBioTherapeutics - Issue of Equity and Total Voting Rights
AnnouncementREG - SkinBioTherapeutics - Acquisition and Financial Update
AnnouncementREG - SkinBioTherapeutics - Notice of Investor Meet Company Presentation
AnnouncementREG - SkinBioTherapeutics - Final testing of SkinBiotix by Croda completed
AnnouncementREG - SkinBioTherapeutics - Holding(s) in Company
AnnouncementREG - SkinBioTherapeutics OptiBiotix Health - Holding(s) in Company
AnnouncementREG - AIM - AIM Notice - 07/08/2024
AnnouncementREG - SkinBioTherapeutics - Investment of £1.56m from new investors
AnnouncementREG - SkinBioTherapeutics - Appointment of Senior Croda VP as Board Advisor
AnnouncementREG - SkinBioTherapeutics - Full year trading update
AnnouncementREG - AIM - AIM Notice - 26/07/2024
AnnouncementREG - AIM - AIM Notice - 24/07/2024
AnnouncementREG - SkinBioTherapeutics - Closure of Convertible Bond Facility
AnnouncementREG - SkinBioTherapeutics - Conversion Notice and Total Voting Rights
AnnouncementREG - SkinBioTherapeutics - Notice of Business Update & Investor Presentation
AnnouncementREG - AIM - AIM Notice - 02/07/2024
AnnouncementREG - SkinBioTherapeutics - Conversion Notice and Total Voting Rights
AnnouncementREG - SkinBioTherapeutics - AxisBiotix Acne study reports positive data
Announcement